» Articles » PMID: 11101508

The Anti-apoptotic Activities of Rel and RelA Required During B-cell Maturation Involve the Regulation of Bcl-2 Expression

Overview
Journal EMBO J
Date 2000 Dec 2
PMID 11101508
Citations 73
Authors
Affiliations
Soon will be listed here.
Abstract

Rel and RelA, individually dispensable for lymphopoiesis, serve unique functions in activated B and T cells. Here their combined roles in lymphocyte development were examined in chimeric mice repopulated with c-rel(-/-) rela(-/-) fetal liver hemopoietic stem cells. Mice engrafted with double-mutant cells lacked mature IgM(lo)IgD(hi) B cells, and numbers of peripheral CD4(+) and CD8(+) T cells were markedly reduced. The absence of mature B cells was associated with impaired survival that coincided with reduced expression of bcl-2 and A1. bcl-2 transgene expression not only prevented apoptosis and increased peripheral B-cell numbers, but also induced further maturation to an IgM(lo)IgD(hi) phenotype. In contrast, the survival of double-mutant T cells was normal and the bcl-2 transgene could not rectify the peripheral T-cell deficit. These findings indicate that Rel and RelA serve essential, albeit redundant, functions during the later antigen-independent stages of B- and T-cell maturation, with these transcription factors promoting the survival of peripheral B cells in part by upregulating Bcl-2.

Citing Articles

The role of NF-κB-SOX9 signalling pathway in osteoarthritis.

Tian B, Zhang L, Zheng J, Kang X Heliyon. 2024; 10(17):e37191.

PMID: 39319133 PMC: 11419907. DOI: 10.1016/j.heliyon.2024.e37191.


Interplay between proteasome inhibitors and NF-κB pathway in leukemia and lymphoma: a comprehensive review on challenges ahead of proteasome inhibitors.

Pakjoo M, Ahmadi S, Zahedi M, Jaafari N, Khademi R, Amini A Cell Commun Signal. 2024; 22(1):105.

PMID: 38331801 PMC: 10851565. DOI: 10.1186/s12964-023-01433-5.


The TRIM21-FOXD1-BCL-2 axis underlies hyperglycaemic cell death and diabetic tissue damage.

Cheng W, Cai C, Xu Y, Xiao X, Shi T, Liao Y Cell Death Dis. 2023; 14(12):825.

PMID: 38092733 PMC: 10719266. DOI: 10.1038/s41419-023-06355-1.


NF-kB's contribution to B cell fate decisions.

Guldenpfennig C, Teixeiro E, Daniels M Front Immunol. 2023; 14:1214095.

PMID: 37533858 PMC: 10391175. DOI: 10.3389/fimmu.2023.1214095.


Venetoclax improves CD20 immunotherapy in a mouse model of MYC/BCL2 double-expressor diffuse large B-cell lymphoma.

Melchor J, Garcia-Lacarte M, Grijalba S, Arnaiz-Leche A, Pascual M, Panizo C J Immunother Cancer. 2023; 11(2).

PMID: 36854569 PMC: 9980368. DOI: 10.1136/jitc-2022-006113.


References
1.
Karin M . How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex. Oncogene. 1999; 18(49):6867-74. DOI: 10.1038/sj.onc.1203219. View

2.
Grillot D, Merino R, PENA J, Fanslow W, Finkelman F, Thompson C . bcl-x exhibits regulated expression during B cell development and activation and modulates lymphocyte survival in transgenic mice. J Exp Med. 1996; 183(2):381-91. PMC: 2192442. DOI: 10.1084/jem.183.2.381. View

3.
Barkett M, Gilmore T . Control of apoptosis by Rel/NF-kappaB transcription factors. Oncogene. 1999; 18(49):6910-24. DOI: 10.1038/sj.onc.1203238. View

4.
Ogilvy S, Metcalf D, Print C, Bath M, Harris A, Adams J . Constitutive Bcl-2 expression throughout the hematopoietic compartment affects multiple lineages and enhances progenitor cell survival. Proc Natl Acad Sci U S A. 1999; 96(26):14943-8. PMC: 24752. DOI: 10.1073/pnas.96.26.14943. View

5.
Grumont R, Gerondakis S . Rel induces interferon regulatory factor 4 (IRF-4) expression in lymphocytes: modulation of interferon-regulated gene expression by rel/nuclear factor kappaB. J Exp Med. 2000; 191(8):1281-92. PMC: 2193138. DOI: 10.1084/jem.191.8.1281. View